Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - CASH & EQUIVALENTS
Cash & Equivalents GLUE - Monte Rosa Therapeutics, Inc.
128 M
LAST VALUE
-39.16%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR